Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer.

Proc Natl Acad Sci U S A · 2026 · PMC13038062 · PMID 41886374

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Tumor microvessel density of the combinatorial treatments was modestly reduced but did not reach statistical significance for EG00229 ( SI Appendix , Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.